Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tyrosine hydroxylase and Parkinson's disease.

Molecular neurobiology - 1 Jun 1998

Haavik J, Toska K

Abstract excerpt

A consistent neurochemical abnormality in Parkinson's disease (PD) is degeneration of dopaminergic neurons in substantia nigra, leading to a reduction of striatal dopamine (DA) levels. As tyrosine hydroxylase (TH) catalyses the formation of L-DOPA, the rate-limiting step in the biosynthesis of DA, the disease can be considered as a TH-deficiency syndrome of the striatum. Similarly, some patients with hereditary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alternative Splicing
Share to Brain
Share to Dystonia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Monoamine Oxidase

Share to Mutation

Share to Parkinson Disease

Share to Tyrosine 3-Monooxygenase

Source

Identifiers

PMID: 9626667
DOI: 10.1007/BF02741387

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tyrosine hydroxylase and Parkinson's disease.PMID 9626667Read ↗

Oxidative stress and Parkinson’s diseaseSemantic proximity Read ↗

Neurochemical and neurogenetic correlates of Parkinson's disease.Semantic proximity Read ↗

The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesisSemantic proximity Read ↗

Tyrosine Hydroxylase Deficiency Impairs TH Axonal Transport, Brain Function, and Neuronal Plasticity.Semantic proximity Read ↗

Prospects for new restorative and neuroprotective treatments in Parkinson's disease.Semantic proximity Read ↗

Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and TyrosinaseSemantic proximity Read ↗

Increased Activity of Tyrosine Hydroxylase Leads to Elevated Amphetamine Response and Markers of Oxidative Stress in Transgenic MiceSemantic proximity Read ↗

Alpha-synuclein facilitates the toxicity of oxidized catechol metabolites: implications for selective neurodegeneration in Parkinson's disease.Semantic proximity Read ↗

Dopamine down-regulation of protein L-isoaspartyl methyltransferase is dependent on reactive oxygen species in SH-SY5Y cells.Semantic proximity Read ↗

Striatal Dysfunctions Associated with Mitochondrial DNA Damage in Dopaminergic Neurons in a Mouse Model of Parkinson's DiseaseSemantic proximity Read ↗

Molecular basis of dopamine replacement therapy and its side effects in Parkinson’s diseaseSemantic proximity Read ↗

Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA TreatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.